CNC Stock Forecast 2025-2026
Distance to CNC Price Targets
CNC Price Momentum
10 Quality Stocks Worth Considering Now
Researching Centene (CNC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CNC and similar high-potential opportunities.
Latest CNC Stock Price Targets & Analyst Predictions
Based on our analysis of 34 Wall Street analysts, CNC has a bullish consensus with a median price target of $80.00 (ranging from $64.00 to $93.00). The overall analyst rating is Buy (7.9/10). Currently trading at $60.70, the median forecast implies a 31.8% upside. This outlook is supported by 11 Buy, 8 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Andrew Mok at Barclays, projecting a 53.2% upside. Conversely, the most conservative target is provided by David Windley at Jefferies, suggesting a 5.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CNC Analyst Ratings
CNC Price Target Range
Latest CNC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CNC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 15, 2025 | Baird | Michael Ha | Neutral | Maintains | $69.00 |
| Apr 9, 2025 | Guggenheim | Jason Cassorla | Neutral | Initiates | $0.00 |
| Apr 8, 2025 | Jefferies | David Windley | Hold | Upgrade | $64.00 |
| Feb 14, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $72.00 |
| Dec 17, 2024 | JP Morgan | John Stansel | Overweight | Assumes | $75.00 |
| Dec 13, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $85.00 |
| Dec 13, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $93.00 |
| Dec 13, 2024 | UBS | A.J. Rice | Buy | Upgrade | $80.00 |
| Dec 13, 2024 | Stephens & Co. | Scott Fidel | Equal-Weight | Maintains | $73.00 |
| Dec 13, 2024 | Truist Securities | Ryan MacDonald | Buy | Maintains | $84.00 |
| Dec 11, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $90.00 |
| Dec 10, 2024 | Jefferies | David Windley | Underperform | Downgrade | $52.00 |
| Nov 4, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $90.00 |
| Oct 30, 2024 | Bernstein | Lance Wilkes | Outperform | Maintains | $88.00 |
| Oct 29, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $91.00 |
| Oct 25, 2024 | Baird | Michael Ha | Neutral | Maintains | $66.00 |
| Oct 1, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $90.00 |
| Sep 20, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $90.00 |
| Sep 13, 2024 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $91.00 |
| Sep 10, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $90.00 |
Centene Corporation (CNC) Competitors
The following stocks are similar to Centene based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Centene Corporation (CNC) Financial Data
Centene Corporation has a market capitalization of $30.11B with a P/E ratio of 9.6x. The company generates $147.17B in trailing twelve-month revenue with a 2.2% profit margin.
Revenue growth is +2.3% quarter-over-quarter, while maintaining an operating margin of +1.5% and return on equity of +12.6%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Centene Corporation (CNC) Business Model
About Centene Corporation
Provides managed care services for government healthcare programs.
Centene generates revenue primarily through its Managed Care and Specialty Services segments. The Managed Care segment offers health plans for Medicaid, Medicare Advantage, and the Health Insurance Marketplace, providing essential services to underserved populations. The Specialty Services segment further enhances its revenue by offering pharmacy solutions, behavioral health, and optometry services, thereby improving healthcare access and affordability.
Founded in 1984 and headquartered in St. Louis, Missouri, Centene is a significant player in the healthcare industry, addressing challenges related to accessibility and cost. The company impacts millions of lives across the U.S. and plays a critical role in shaping healthcare policy and market trends.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
60,500
CEO
Ms. Sarah M. London
Country
United States
IPO Year
2001
Website
www.centene.comCentene Corporation (CNC) Latest News & Analysis
Centene (CNC) is expected to report earnings that may exceed forecasts due to favorable conditions. Investors should be prepared for the upcoming report.
Centene's potential for an earnings beat could signal strong financial performance, influencing stock prices and investor sentiment positively.
Health Net and the Centene Foundation announced a $750,000 commitment for wildfire recovery efforts in Los Angeles County, aiming to coordinate critical healthcare infrastructure recovery.
The $750,000 commitment from Health Net and Centene Corporation highlights a focus on community health recovery, potentially enhancing their reputation and long-term stability in the healthcare market.
CNC's subsidiary, SilverSummit, has obtained a five-year Medicaid contract in Nevada, strengthening its position in managed care for rural and frontier regions.
CNC's contract strengthens its position in managed care, potentially boosting revenue and market share in underserved regions, which could enhance overall company performance and investor confidence.
During a historic four-day market decline, only a few S&P 500 stocks achieved gains.
The limited gainers in a significant market drop signal potential weakness in the overall market, indicating increased risk and volatility for investors.
The Zacks Earnings ESP tool helps investors identify stocks likely to exceed quarterly earnings estimates, enhancing investment decision-making.
The Zacks Earnings ESP tool can identify stocks likely to beat earnings estimates, potentially leading to price increases and better investment returns.
Health Net and the Centene Foundation announced a partnership investment exceeding $9 million to enhance California's physician workforce, addressing barriers from youth to medical school.
The investment aims to strengthen the physician workforce in California, potentially improving healthcare access and quality, which can influence Centene Corporation's long-term growth and profitability.
Frequently Asked Questions About CNC Stock
What is Centene Corporation's (CNC) stock forecast for 2025?
Based on our analysis of 34 Wall Street analysts, Centene Corporation (CNC) has a median price target of $80.00. The highest price target is $93.00 and the lowest is $64.00.
Is CNC stock a good investment in 2025?
According to current analyst ratings, CNC has 11 Buy ratings, 8 Hold ratings, and 0 Sell ratings. The stock is currently trading at $60.70. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CNC stock?
Wall Street analysts predict CNC stock could reach $80.00 in the next 12 months. This represents a 31.8% increase from the current price of $60.70. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Centene Corporation's business model?
Centene generates revenue primarily through its Managed Care and Specialty Services segments. The Managed Care segment offers health plans for Medicaid, Medicare Advantage, and the Health Insurance Marketplace, providing essential services to underserved populations. The Specialty Services segment further enhances its revenue by offering pharmacy solutions, behavioral health, and optometry services, thereby improving healthcare access and affordability.
What is the highest forecasted price for CNC Centene Corporation?
The highest price target for CNC is $93.00 from Andrew Mok at Barclays, which represents a 53.2% increase from the current price of $60.70.
What is the lowest forecasted price for CNC Centene Corporation?
The lowest price target for CNC is $64.00 from David Windley at Jefferies, which represents a 5.4% increase from the current price of $60.70.
What is the overall CNC consensus from analysts for Centene Corporation?
The overall analyst consensus for CNC is bullish. Out of 34 Wall Street analysts, 11 rate it as Buy, 8 as Hold, and 0 as Sell, with a median price target of $80.00.
How accurate are CNC stock price projections?
Stock price projections, including those for Centene Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.